Motion for a resolution - B9-0169/2022Motion for a resolution
B9-0169/2022

MOTION FOR A RESOLUTION on creating a European compensation fund for victims of the COVID-19 vaccines:

17.3.2022

pursuant to Rule 143 of the Rules of Procedure
– Comirnaty (Pfizer, BioNTech)
– Janssen COVID-19 vaccine
– Spikevax (Moderna vaccine)
– Vaxzevria (AstraZeneca vaccine)

Virginie Joron, Annika Bruna, Markus Buchheit, Susanna Ceccardi, Gianantonio Da Re, Francesca Donato, Jean‑Paul Garraud, Mislav Kolakušić, Joachim Kuhs, Hélène Laporte, Julie Lechanteux, Sylvia Limmer, Robert Roos, Ivan Vilibor Sinčić

B9‑0169/2022

Motion for a European Parliament resolution on creating a European compensation fund for victims of the COVID-19 vaccines

 

The European Parliament,

 having regard to Rule 143 of its Rules of Procedure,

A. whereas the European Medicines Agency (EMA) has already recorded around a million cases of people experiencing adverse reactions from the COVID-19 vaccines:

– 582 074 due to the Pfizer BioNTech vaccine,

– 244 603 due to the AstraZeneca vaccine,

– 150 807 due to the Moderna vaccine,

– 40 766 due to the Janssen vaccine[1];

B. whereas these adverse reactions are sometimes severe – for example, a 13-year-old child reportedly lost 90% of their sight after a first dose of Pfizer vaccine[2];

C. whereas the EMA states that around 10 000 people have died in the EU as a result of taking the COVID-19 vaccines:

– 7 023 due to the Pfizer vaccine,

– 1 447 due to the AstraZeneca vaccine,

– 834 due to the Moderna vaccine,

– 279 due to the Janssen vaccine,

D. whereas the European Commission negotiated the purchase contracts and did not wish for the pharmaceutical companies to incur any liability; whereas, moreover, MEPs were not granted access to the contracts during the negotiations;

1. Calls on the Commission to create a European compensation fund for victims of the COVID-19 vaccines;

2. Instructs its President to forward this resolution to the Commission and the Member States.

Last updated: 25 March 2022
Legal notice - Privacy policy